Management of Cancer-Related Pain

Emergency Medicine Clinics of North America

Volumn 27, Issue 2, 2009, Pages 179-194

  DeSandre, Paul L ^a   Quest, Tammie E ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Emergency department; Malignant; Opioids; Pain

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIHISTAMINIC AGENT; CODEINE; CODEINE DERIVATIVE; CORTICOSTEROID; DEXAMETHASONE; DEXTROPROPOXYPHENE; DICLOFENAC; DRUG METABOLITE; FENTANYL; FENTANYL CITRATE; HYDROCODONE; HYDROMORPHONE; KETOROLAC; METHADONE; MISOPROSTOL; MORPHINE; MORPHINE 6 GLUCURONIDE; MORPHINE DERIVATIVE; NALOXONE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; NORPETHIDINE; OMEPRAZOLE; OXYCODONE; PARACETAMOL; PETHIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL PAIN; ANAPHYLAXIS; ANOREXIA; BOLUS EFFECT SYNDROME; BONE ATROPHY; BONE METASTASIS; BONE PAIN; BRONCHOSPASM; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL FEATURE; CONFUSION; CONSTIPATION; CONTINUOUS INFUSION; DELIRIUM; DEPRESSION; DROWSINESS; DRUG CROSS TOLERANCE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INTERMITTENT THERAPY; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPHORIA; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; KIDNEY FAILURE; LIVER TOXICITY; MAXIMUM PLASMA CONCENTRATION; MYOCLONUS; MYOPATHY; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; OSTEOARTHRITIS; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT CONTROLLED ANALGESIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PRURITUS; PSYCHOSIS; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SEIZURE; SIDE EFFECT; SPINAL CORD COMPRESSION; STEROID PSYCHOSIS; STOMACH DISEASE; THROMBOCYTE AGGREGATION INHIBITION; THRUSH; TIME TO MAXIMUM PLASMA CONCENTRATION; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; URTICARIA; VISCERAL PAIN; VOMITING;

EID: 65549106553     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2009.01.002     Document Type: Review

References (35)

1. van den Beuken-van Everdingen M.H., de Rijke J.M., Kessels A.G., et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18 9 (2007) 1437-1449
2. Ventafridda V.O.E., and Caraceni A. A retrospective study on the use of oral morphine in cancer pain. J Pain Symptom Manage 2 (1987) 77-82
3. Walker V.A., Hoskin P.J., Hanks G.W., et al. Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage 3 (1988) 145-149
4. Goisis A., Gorini M., Ratti R., et al. Application of a WHO protocol on medical therapy for oncologic pain in an internal medicine hospital. Tumori 75 (1989) 470-472
5. Caraceni A., Martini C., Zecca E., et al. Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Pa Med 18 (2004) 177-183
6. Zech D.F., Grond S., Lynch J., et al. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63 (1995) 65-76
7. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer 85 (1999) 1849-1858
8. Moryl N., Coyle N., and Foley K.M. Managing an acute pain crisis in a patient with advanced cancer: "this is as much of a crisis as a code". JAMA 299 12 (2008) 1457-1467
9. Todd K.H. Pain assessment instruments for use in the emergency department. Emerg Med Clin North Am 23 (2005) 285-295
10. Ramer L., Richardson J.L., Cohen M.Z., et al. Multimeasure pain assessment in an ethnically diverse group of patients with cancer. J Transcult Nurs 10 (1999) 94-101
11. DeWaters T., Faut-Callahan M., McCann J.J., et al. Comparison of self-reported pain and the PAINAD scale in hospitalized cognitively impaired and intact older adults after hip fracture surgery. Orthop Nurs 27 1 (2008) 28-30
12. Zwakhalen S.M., hamers J.P., and Berger M.P. The psychometric quality and clinical usefulness of three pain assessment tools for elderly people with dementia. Pain 126 1-3 (2006) 210-220
13. Foley K.M. Acute and chronic cancer pain syndromes. In: Doyle D., Hanks G., Cherny K., et al. (Eds). Oxford textbook of palliative medicine (2004), Oxford University Press, New York 298-316
14. Bruera E., Neumann C.M., Gagnon B., et al. Edmonton Regional Palliative Care Program: impact on patterns of terminal cancer care. CMAJ 161 3 (1999) 290-293
15. Breitbart W., Chochinov H.M., and Passik S.D. Psychiatric symptoms in palliative medicine. In: Doyle D., Hanks G., Cherny K., et al. (Eds). Oxford textbook of palliative medicine (2004), Oxford University Press, New York 746-771
16. Casarett D., Pickard A., Bailey F.A., et al. "Do palliative consultations improve patient outcomes?". J Am Geriatr Soc 56 4 (2008) 593-599
17. Bruhlmann P., Florent d.V., Dreiser, et al. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies. Curr Med Res Opin 22 12 (2006) 2429-2438
18. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28 5 (2004) 497-504
19. Broadbent A., Khor K., and Heaney A. Palliation and chronic renal failure: opioid and other palliative medications - dosage guidelines. Progr Palliat Care 11 4 (2003) 183-190
20. Murphy E.J. Acute pain management pharmacology for the patient with concurrent renal or hepatic disease. Anaesth Intensive Care 33 3 (2005) 311-322
21. Estfan B., Mahmoud F., Shaheen P., et al. Respiratory function during parenteral opioid titration for cancer pain. Pa Med 21 2 (2007) 81-86
22. Smith L.H. Opioid safety: is your patient at risk for respiratory depression?. Clin J Oncol Nurs 11 2 (2007) 293-296
23. Abrams J.L. Pharmacological management of cancer pain. A physician's guide to pain and symptom management in cancer patients (2005), The Johns Hopkins University Press, Baltimore (MD) p. 197-9, 242
24. Skaer T.L. Practice guidelines for transdermal opioids in malignant pain. Drugs 64 23 (2004) 2629-2638
25. Portenoy R.K., and Hagen N.A. "Breakthrough pain: definition, prevalence and characteristics". Pain Headache 41 (1990) 273-282
26. Cherny N., Ripamonti C., Pereira J., et al., Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19 9 (2001) 2542-2554
27. Krajnik M., Zylicz Z., Finlay I., et al. Potential uses of topical opioids in palliative care-report of 6 cases. Pain 80 1-2 (1999) 121-125
28. Zeppetella G., Paul J., and Ribeiro M.D.C. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 25 (2003) 555-558
29. Zeppetella G., and Ribeiro M.D.C. Morphine in Intrasite gel applied topically to painful ulcers. J Pain Symptom Manage 29 (2005) 118-119
30. Portenoy R.K., Thomas J., Boatwright M.L.M., et al. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage 35 (2008) 458-468
31. Thomas J., Karver S., Cooney G.A., et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 358 (2008) 2332-2343
32. Mercadante S., Villari P., Ferrera P., et al. "Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion". Cancer 95 1 (2002) 203-208
33. Soares L.G.L., Martins M., and Uchoa R. Intravenous fentanyl for cancer pain: a "Fast Titration" protocol for the emergency room". J Pain Symptom Manage 26 3 (2003) 876-881
34. Hagen N.A., Elwood T., and Ernst S. "Cancer pain emergencies: a protocol for management". J Pain Symptom Manage 14 1 (1997) 45-50
35. The EPEC Project. Module 12: Malignant Pain. In: Emanuel L.L., and Quest T.E. (Eds). The education in palliative and end-of-life care-emergency medicine (EPEC-EM) trainer's guide (2008), Northwestern University, Chicago (IL)